DAYS
SPEAKERS
TALKS
SPONSORS
Conference Objectives
- Update about neurogenetic disorders clinical approach, diagnosis & management
- Update about leukodystrophies
- Update about genetic causes and treatment of epileptic encehalopathies
- Over view and update about neurotransmitters disorders
- Update about treatment of metabolic epilepsies
- Clinical approach and treatment to pediatric movement disorders
Meet the speakers
Laura A Adang, (MD, PhD)
Prof. Majid Alfadhel (MD, MHSc, SSC-Ped, ABHS(CH), FCCMG)
Dr. Fuad Al Mutairi
Dr. Amna Abdulkarim Kashgari (MD)
Prof. Fahad A. Bashiri (MBBS, ABP, SCCP, KSUBP, KFSH PNF, UBC Epilepsy Fellowship)
Dr. Makki Almuntashri (MD, FRCPC, DABR)
Dr. Muhammad Talal Alrifai (MD)
Prof. Mohammad A Al-Muhaizea (MD, MBA (IHM))
Conference Agenda
Day 1, Friday 2nd July, 2021
Leukodystrophies
Diagnostic Algorithm for Leukodystrophies
The diagnosis and management of Aicardi Goutieres Syndrome
The Leukodystrophy Spectrum in Saudi Arabia: Epidemiological, Clinical, Radiological and Genetic Data
Artificial intelligence utility in diagnosing Leukodystrophies
Day 2, Saturday 3rd July, 2021
Approach to pediatric neurometabolic/genetic disease
Approach to neuro-metabolic disorders: pediatric neurology point of view
Neuroimaging in neurogenetics disorders
Neurogenetics approach to ataxia
Neurogenetics approach to hypotonia
Therapeutic implications of genetic testing in movement disorders: real life experience
Utility of NGS in diagnosis of neurogenetic disorders
Novel neurogenetic disorders in Saudi Arabia-An update
What is the right sequencing approach? Solo VS extended family analysis in consanguineous population
Mitochondrial disorders in Saudi Arabia
Epileptic encephalopathies and neurotransmitters disorders
Treatable metabolic epilepsies
Genetic epileptic encephalopathies: treatment update
Pyridoxine dependent epilepsy in Saudi Arabia
Neurotransmitter’s disorder: over view and update